CG Oncology, Inc. Common stockCGONNASDAQ

Revenue (LTM)

$4M

+254.7% YoY

Net Income (LTM)

$-161M

-82.9% YoY

Free Cash Flow

$-132M

Revenue CAGR (5Y)

-21.0%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	10	0↓98.2%	0↑6.8%	1↑458.3%	4↑254.7%
Gross Profit	10	0↓98.3%	0↑15.9%	1↑458.3%	-1↓153.3%
Operating Income	-13	-35↓179.6%	-55↓57.3%	-115↓106.8%	-191↓66.4%
Net Income	-13	-35↓176.1%	-49↓37.1%	-88↓81.1%	-161↓82.9%
EBITDA	-12	-35↓184.6%	-55↓57.3%	-115↓106.8%	-160↓39.2%
EPS Diluted	-0.28	-0.66↓135.7%	-1.02↓54.5%	-1.41↓38.2%	-2.08↓47.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	54	88↑64.4%	8↓90.6%	257↑3009.9%	32↓87.4%
Total Current Assets	58	147↑152.0%	194↑31.9%	754↑288.5%	759↑0.7%
Total Assets	59	148↑151.7%	199↑34.9%	755↑278.7%	792↑4.9%
Total Current Liabilities	6	15↑158.2%	14↓7.6%	21↑49.9%	31↑44.3%
Total Liabilities	18	23↑22.4%	15↓35.7%	21↑47.6%	39↑82.0%
Total Equity	40	125↑211.0%	185↑47.6%	733↑296.9%	753↑2.6%
Total Debt	15	16↑5.4%	1↓93.5%	0↓76.9%	7↑2850.0%
Net Debt	-38	-72↓87.6%	-7↑90.0%	-257↓3449.3%	-25↑90.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-14	-30↓118.3%	-46↓53.3%	-79↓72.3%	-132↓68.1%
Capital Expenditure	-0	-0↑85.6%	0	-0	-0↑42.7%
Free Cash Flow	-14	-30↓116.8%	-46↓53.2%	-79↓72.8%	-132↓67.8%
Stock-Based Comp	1	1↓39.2%	2↑126.0%	11↑646.2%	27↑134.0%
Net Change in Cash	2	35↑1937.5%	-80↓331.3%	249↑411.5%	-225↓190.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance